Health Condition 1: C500- Malignant neoplasm of nipple and areola
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Sponsors
Dr Navdeep Kaur Lubana
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients must have malignant breast lesions. 2. Patients must consent to take part in the study.
Exclusion criteria
Exclusion criteria: Patients who do not provide informed consent to participate in the study. Patients with Paget s disease of the breast. Patients diagnosed with benign breast lesions. Patients with recurrent breast cancer. Patients who have received prior radiotherapy to the breast. Patients who are medically unfit to undergo surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the involvement of nipple areolar complex in breast cancer and to find out predictors of nipple areolar complex involvement in Breast CancerTimepoint: 2 week after mastectomy | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the involvement of nipple areolar complex in malignant Breast CancerTimepoint: 2 week after mastectomy;To find out predictors of nipple areolar complex involvement in breast cancer like tumor size, location, distance of tumor from NAC, tumor depth, BIRADS category, Receptor statusTimepoint: 2 week after mastectomy | — |
Countries
India
Contacts
Public ContactDr Sanjeev Kumar
Dr Rajendra Prasad Government
Outcome results
None listed